Kim Hardy

Design and Synthesis of a Novel and Potent Series of Inhibitors of Cytosolic Phospholipase A₂ Based on a 1,3-Disubstituted Propan-2-one Skeleton

Stephen Connolly, Colin Bennion, Sarah Botterell et al. · Journal of Medicinal Chemistry · 2002 · 84 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

A highly invasive human glioblastoma pre-clinical model for testing therapeutics

Qian Xie, Ryan C. Thompson, Kim Hardy et al. · Journal of Translational Medicine · 2008 · 59 citations · Full text

Medicine, Oncology, Pharmacology +17

Discovery of new non-phospholipid inhibitors of the secretory phospholipases A2

Haydn G. Beaton, Colin Bennion, Stephen Connolly et al. · Journal of Medicinal Chemistry · 1994 · 48 citations · Full text

Medicine, Biochemistry, Pharmacology +8

Mitogen-activated protein kinase kinase signaling promotes growth and vascularization of fibrosarcoma

Yan Ding, Elissa A. Boguslawski, Bree D. Berghuis et al. · Molecular Cancer Therapeutics · 2008 · 37 citations · Full text

Medicine, Cancer Biology, Cell Biology +17

Synthesis and evaluation of substrate-mimicking cytosolic phospholipase A2 inhibitors––reducing the lipophilicity of the arachidonyl chain isostere

Iain A. S. Walters, Colin Bennion, Stephen Connolly et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 14 citations

Life Sciences, Biochemistry, Pharmacology +12